Repeated peptide receptor radiotherapy in multiple recurrences of a metastasized neuroendocrine tumor

Nuklearmedizin. 2017 Jun 12;56(3):N19-N21. doi: 10.3413/Nukmed-0863-16-11. Epub 2017 Mar 30.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Intestinal Neoplasms / diagnostic imaging
  • Intestinal Neoplasms / drug therapy
  • Intestinal Neoplasms / pathology
  • Intestinal Neoplasms / radiotherapy*
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / radiotherapy*
  • Neuroendocrine Tumors / diagnostic imaging
  • Neuroendocrine Tumors / drug therapy
  • Neuroendocrine Tumors / pathology
  • Neuroendocrine Tumors / radiotherapy*
  • Octreotide / analogs & derivatives*
  • Octreotide / therapeutic use
  • Organometallic Compounds / therapeutic use*
  • Pancreatic Neoplasms / diagnostic imaging
  • Pancreatic Neoplasms / drug therapy
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / radiotherapy*
  • Positron Emission Tomography Computed Tomography
  • Protein Kinase Inhibitors / therapeutic use
  • Radiopharmaceuticals / therapeutic use*
  • Stomach Neoplasms / diagnostic imaging
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / radiotherapy*

Substances

  • Ga(III)-DOTATOC
  • Organometallic Compounds
  • Protein Kinase Inhibitors
  • Radiopharmaceuticals
  • 90Y-octreotide, DOTA-Tyr(3)-
  • lutetium Lu 177 dotatate
  • Octreotide

Supplementary concepts

  • Gastro-enteropancreatic neuroendocrine tumor